Trial Profile
Weekly Paclitaxel Liposome Injection Plus Cisplatin in Preoperative Treatment of Breast Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Cisplatin
- Indications Breast cancer
- Focus Therapeutic Use
- Sponsors Nanjing Sike Pharmaceutical
- 26 Aug 2014 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified Aug 2014)
- 26 Aug 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov
- 22 May 2014 New trial record